Pharma companies settle M&A dispute
Multinational pharmaceutical companies Teva and Allergan have agreed a US$700 million settlement of a dispute over the value of a generic drug business that Teva acquired in a US$40.5 billion deal.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10